Armata Pharmaceuticals (ARMP) Treasury Shares (2018 - 2026)
Armata Pharmaceuticals' (ARMP) quarterly Treasury Shares came in at $135000.0 in Q1 2026, down 33.33% year-on-year from $202500.0 in Q1 2025, and down 11.48% quarter-over-quarter from $152500.0 in Q4 2025.
Armata Pharmaceuticals (ARMP) Treasury Shares (2018 - 2026) Analysis & Trends
Armata Pharmaceuticals has disclosed Treasury Shares across 9 years of filings, most recently posting $135000.0 for Q1 2026.
- Treasury Shares for Q1 2026 came in at $135000.0, down 33.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $135000.0 (down 33.33% YoY), and the FY2025 annual result was $152500.0, down 30.68% from the prior year.
- Treasury Shares came in at $135000.0 for Q1 2026 at Armata Pharmaceuticals, down from $152500.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $290000.0 in Q1 2024 to a low of $9748.0 in Q2 2023.
- The 5-year median for Treasury Shares is $152500.0 (2025), against an average of $158374.6.
- Across the five-year window, Treasury Shares tumbled 92.48% in 2023 and soared 2874.97% in 2024, its largest moves.
- Armata Pharmaceuticals' Treasury Shares stood at $30000.0 in 2022, then soared by 566.67% to $200000.0 in 2023, then gained by 10.0% to $220000.0 in 2024, then sank by 30.68% to $152500.0 in 2025, then dropped by 11.48% to $135000.0 in 2026.
- The last three Treasury Shares figures came in at $135000.0 (Q1 2026), $152500.0 (Q4 2025), and $152500.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Armata Pharmaceuticals | 275.44 Mn | 270.68 Mn | - | 135,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 135,000.00 |
| Mar 31, 2026 | 135,000.00 |
| Dec 31, 2025 | 152,500.00 |
| Dec 31, 2025 | 152,500.00 |
| Sep 30, 2025 | 152,500.00 |
| Sep 30, 2025 | 152,500.00 |
| Jun 30, 2025 | 202,500.00 |
| Jun 30, 2025 | 202,500.00 |
| Mar 31, 2025 | 202,500.00 |
| Mar 31, 2025 | 202,500.00 |
| Dec 31, 2024 | 220,000.00 |
| Dec 31, 2024 | 220,000.00 |
| Sep 30, 2024 | 230,000.00 |
| Sep 30, 2024 | 230,000.00 |
| Jun 30, 2024 | 290,000.00 |
| Jun 30, 2024 | 290,000.00 |
| Mar 31, 2024 | 290,000.00 |
| Mar 31, 2024 | 290,000.00 |
| Dec 31, 2023 | 200,000.00 |
| Dec 31, 2023 | 200,000.00 |